Table 3.
Health characteristics by drug use category – United States, 2015–2018.
| Characteristic | Weighted % (95 % CI) | ||
|---|---|---|---|
| Opioid use (N = 1511) | Methamphetamine use (N = 1081) | Opioid and Methamphetamine use (N = 397) | |
| Fair/poor health | 28.4 (24.6–32.1) | 25.7 (22.1–29.4) | 32.3 (25.1–39.4) |
| Any infectious disease | 12.0 (10.0–14.0) | 15.9 (12.0–19.9) | 21.8 (16.7–27.0)a,e |
| STI (past year) | 6.2 (4.8–7.6) | 9.1(6.6–11.6)c | 9.6 (5.8–13.4)c |
| HIV/AIDS | 0.6 (0.0–1.1) | 3.5 (1.5–5.5)b | 1.0 (−0.5–2.4) |
| Hepatitis B or C | 6.7 (4.9–8.5) | 6.9 (3.9–9.9) | 12.2 (8.8–15.6)b,e |
| Any respiratory disease | 11.6 (9.4–13.8) | 16.7 (13.8–19.6)b | 17.8 (11.9–23.7)c |
| Asthma | 7.4 (5.9–8.9) | 8.3 (6.7–10.0) | 7.2 (3.6–10.8) |
| COPD | 6.3 (4.6–7.9) | 10.4 (7.6–13.1)b | 12.9 (7.5–18.2)b |
| Any cardiovascular disease | 19.5 (15.8–23.1) | 17.3 (13.7–20.9) | 25.2 (18.5–32.0)e |
| Heart condition | 8.0 (5.6–10.3) | 7.6 (5.6–9.6) | 11.5 (5.7–17.3) |
| High blood pressure | 14.8 (11.4–18.2) | 12.6 (9.2–15.9) | 20.7 (14.4–27.0)d |
| Diabetes | 8.2 (6.1–10.2) | 7.0 (4.8–9.2) | 5.7 (1.8–9.6) |
| Kidney disease | 0.9 (0.3–1.5) | 2.0 (0.7–3.2) | * |
| Cancer | 2.4 (1.4–3.3) | 3.7 (1.5–5.8) | 3.5 (1.1–5.9) |
| Chronic Conditions per 100 individuals | 55.1 (47.7–62.4) | 62.5 (54.9–70.0) | 75.2 (61.5–89.0)b |
| Any disability | 37.7 (34.0–41.4) | 40.0 (35.6–44.3) | 42.1 (35.4–48.7) |
| Severe mental illness | 20.7 (17.3–24.0) | 22.8 (17.8–27.8) | 32.1 (25.0–39.1)b |
| Uninsured | 20.6 (17.9–23.3) | 22.6 (19.3–25.9) | 24.9 (18.0–31.9) |
All estimates are adjusted for age, sex, income, education, rural vs. urban residence, race/ethnicity, and housing instability in the past year.
Opioid use is defined as any past year heroin use or misusing prescription pain relievers 4 or more times in the past month. Methamphetamine use is defined as any past year methamphetamine use.
a
P≤.0.001 compared to “Opioid use”.
b
P≤.0.01 compared to “Opioid use”.
c
P≤.0.05 compared to “Opioid use”.
d
P≤.0.01 compared to “Methamphetamine use”.
e
P≤.0.05 compared to “Methamphetamine use”.
*
Estimate did not pass the NSDUH suppression requirements.